The 2017 Large Print Pharmacopoeia is Now Available

Same Price. Same Content. Larger Print.

Featuring the same content as the Tarascon Pocket Pharmacopoeia 2017 Classic Shirt-Pocket Edition but with larger, easier-to-read print, the Large Print Edition continues its tradition as the leading portable drug reference packed with vital drug information to help clinicians make better decisions at point of care.

New to the 2017 Edition:

  • Updated with new drug information
  • New drugs reflect updated FDA Pregnancy and Lactation Labeling Rule (PLLR)
  • FDA guideline updates
  • Removal of discontinued drugs and outdated dosing information

Visit our website to get your copy of the Large Print: Tarascon Pocket Pharmacopoeia 2017 Classic Shirt-Pocket Edition.

Posted in General Medicine, Pharma, Primary Care | Tagged , , , , , , , | Comments Off on The 2017 Large Print Pharmacopoeia is Now Available

The 2017 Tarascon Catalog is Here!

The World Leading Provider of Portable Medical References

View the catalog now or download a printable version.

Visit our website to learn more about us and to SAVE on Tarascon today.

Posted in General Medicine, Prescribing, Primary Care | Tagged , , , , , , , | Comments Off on The 2017 Tarascon Catalog is Here!

10 Things You May Not Know About Tarascon

You know how invaluable the Tarascon Pharmacopoeia is, but do you know the Tarascon story?

Here are 10 things you may not know about Tarascon:

  1. The Tarascon Series is named after the Tarascon castle in France where the original author was visiting when he decided to turn his “cheat sheet” of drug information into a published book.
  2. Every year we include a trivia question in the Classic and Deluxe books. The first 25 people who find it and respond with the correct answer get a prize.
  3. You can now find Tarascon Pharmacopoeia drug information in EvidenceCare’s unique online decision support tool for providers
  4. Our editor-in-chief, Richard Hamilton, was the Centrifuge Medical Officer for the NASTAR Center during the training of a number of astronauts as well as the Virgin Galactic Founders.
  5. Tarascon was acquired by Jones and Bartlett Publishing in 2008.
  6. The same image has been featured on the print versions of the Pharmacopoeia for the past 31 years (The Apothecary, by Jost Amman, Frankfurt, 1574), although each year we choose a new color.
  7. You can find Tarascon books all over the world! Various pocketbooks have been translated into Spanish, Indonesian, Simplified Chinese, Greek, Romanian, and Turkish.
  8. There are over 3,000 drugs and over 1,200 drug interactions in the mobile version of the Pharmacopoeia.
  9. The mobile edition started out as a reference tool for PDAs. Now we have mobile apps that are updated weekly and separate apps based on several of our Pocketbooks.
  10. The Tarascon editorial team believes in giving back! We are proud to have donated money and/or books to Doctors Without Borders, hospitals, and clinics in Africa, Asia, Europe, and North America.

Visit our website to learn more about us and to view our entire catalog of Tarascon titles.

Posted in Mobile Medicine, Reviews, Social Media | Tagged , , , , , , | Comments Off on 10 Things You May Not Know About Tarascon

The 2017 Tarascon Pharmacopoeias Are Here!

pharma_2xAsk anyone at Tarascon, our favorite time of year is when we get to announce the new editions of the Tarascon Pharmacopoeias. The 2017 editions of the most popular and trusted source of portable drug information are here! The Tarascon Pharmacopoeia features new drugs that reflect the updated FDA Pregnancy and Lactation Labeling Rule (PLLR) and of course has been updated with the latest FDA Guidelines and new drug information.

The 2017 Tarascon Pharmacopoeia is available in a variety of formats:

Remember, “it’s not how much you know, it’s how fast you can find the answer.”

Visit to learn more about the 2017 Tarascon Pocket Pharmacopoeias and all of the invaluable, portable medical references Tarascon offers.

Connect with Tarascon on Facebook for updates, special offers, and promotions.

Posted in General Medicine, Pharma, Primary Care | Tagged , , , , , , , | Comments Off on The 2017 Tarascon Pharmacopoeias Are Here!

Tarascon Pharmacopoeia Now Integrated in EvidenceCare Unique Online Platform

2016_ClassicTarascon and EvidenceCare Together,
Bringing Vital Information to Doctors’ Fingertips

EvidenceCare, a Nashville-based decision support tool for healthcare providers, announces the integration of drug information from Tarascon Pharmacopoeia, the most popular and trusted source of portable drug information since 1987. The integration provides EvidenceCare the opportunity to deliver content that has been relied upon by Providers worldwide for nearly three decades. EvidenceCare presents the information in a format that is easy-to-access and is personalized to each unique patient.

“The Tarascon Pharmacopoeia pocket guide has been a staple for me since medical school,” noted EvidenceCare CEO and Founder, Dr. Brian Fengler. “We have partnered with industry experts to put decision support in the hands of providers. Having the vital information published by Tarascon simply makes sense as we round out our Antibiotic Guide.”

Tarascon Publishing, an imprint of Jones & Bartlett Learning, publishes pocket guides that succinctly distill and organize hard-to-remember, yet vitally important clinical information. Tarascon content is available within every EvidenceCare pathway, clearly identified by the company’s logo. Combining that content with the innovative delivery mechanism created by Fengler provides a refreshing context for acclaimed Tarascon resources.

“We are frequently approached to leverage our content,” stated Ed Moura, General Manager for Jones & Bartlett Learning. “EvidenceCare’s delivery is unlike anything we have seen. We are excited about bringing our content to a new audience in a fresh way.”

EvidenceCare was pioneered by Fengler, an emergency room physician, and offers a unique dashboard interface that presents treatment recommendations based on the unique factors of each specific patient. Providers of all types appreciate the ease-of-useevidencecare_logo and the fact that it works the way they do, in line with their workflow. The solution is available anywhere there is an internet connection and doesn’t require IT resources to get rolling.

EvidenceCare launched nation-wide in summer 2016 with pathways for the conditions seen most by providers, a comprehensive Antibiotic Guide which incorporates Tarascon data, an independent Tarascon Pharmacopoeia Guide, and a USPSTF Guide. Pathway content has been developed by industry-leading experts and is curated specifically for each patient. The company offers subscription models for physicians, mid-levels and nurses, ranging from an ad-supported free version to subscription options that include a patient presentation feature, documentation packaging for any EHR with a single click, and CME credit for the time a provider spends working in the tool. In addition, the company offers integrated enterprise solutions for health systems and hospitals.

EvidenceCare is extending a 40% discount off the premium edition with the Promo Code TARASCON40. If you choose the free option, you can always upgrade using the code TARASCON40. Learn how you can save 40% on EvidenceCare.

Learn more about EvidenceCare’s unique online decision support tool for healthcare providers by visiting

Posted in General Medicine, Jones & Bartlett Learning, Mobile Medicine, Prescribing, Uncategorized | Tagged , , , , , , , , , | Comments Off on Tarascon Pharmacopoeia Now Integrated in EvidenceCare Unique Online Platform

Just Published: The Complete Guide to ECGs, Fourth Edition

OKeefe_2The highly anticipated fourth edition of the must-have ECG interpretation resource is now available.  The Complete Guide to ECGs has been developed as a unique and practical means for physicians, physicians-in-training, and other medical professionals to improve their ECG interpretation skills. The highly interactive format and comprehensive scope of information are also ideally suited for physicians preparing for the American Board of Internal Medicine (ABIM) Cardiovascular Disease or Internal Medicine Board Exams, the American College of Cardiology ECG proficiency test, and other exams requiring ECG interpretation.

The Complete Guide to ECGs, Fourth Edition is a superb addition to the library of every intern, resident, and fellow, and a uniquely practical and comprehensive study guide for physicians interested in improving their interpretation of ECGs and preparing for board examinations.

Would you like to learn more about this must-have resource for cardiologists? Visit our website.

Posted in Cardiology, General Medicine, Jones & Bartlett Learning | Tagged , , , , , , , | Comments Off on Just Published: The Complete Guide to ECGs, Fourth Edition

Recently Published: 100 Questions & Answers About Schizophrenia

DeLisi_QA_Schizophrenia_BigSchizophrenia and its related conditions are all too common among young adults and are prevalent in about 1% of the general population. This is a devastating disorder of thinking; if gone undetected and thus untreated it can lead to robbing an individual of his or her life’s goals and aspirations as it develops. If unchecked, it can lead to either suicidal or violent behavior towards others because the affected individual may become plagued by increasing paranoia, bothersome auditory hallucinations commanding various actions, and a general withdrawal from reality. Lately some unfortunate cases of developing schizophrenia have made the news because of the tragic and deadly events they initiated. These have spurred controversial gun control debates and have brought mental illness to the forefront of these debates about government legislation nationally.

Currently, however, we do have the availability of many medications that if administered early to people developing these symptoms, can lead to recovery and the maintenance of a good quality of life. Doctors and other clinicians who initially see these individuals need to know which of these medications would be helpful and how to use them. There are also many new research findings that examine the brain and genetic make-up of people who develop schizophrenia. These can ultimately lead to new and better treatments and preventive measures.

When a family member has schizophrenia, often a parent does not know whom to turn. 100 Questions and Answers about Schizophrenia, Third Edition provides guidance and understanding about the illness and is a resource for letting family members and individuals suffering from the disease to know where they can go for help and support. It is also a guide for clinicians in the community and other healthcare providers who do not see these patients on an everyday basis and thus may miss the signs and symptoms.

Post written by Lynn E. DeLisi, MD. Dr. DeLisi is the author of 100 Questions & Answers About Schizophrenia and is a professor of psychiatry at New York University and associate director of the Center for Advanced Brain Imaging at The Nathan S. Kline Institute for Psychiatric Research. She is international editor-in-chief of the journal, Schizophrenia Research, and a member of the editorial board of several journals. She has co-authored over 250 scientific publications and has edited or written other scientific books.

Posted in Authors, General Medicine, Patient Education, Pyschiatry & Mental Health | Tagged , , , , , | Comments Off on Recently Published: 100 Questions & Answers About Schizophrenia

Leap Year is Also Rare Disease Day!


To celebrate this year’s Rare Disease Day, The Tarascon Team is offering a One Day App Sale on all new downloads of our Tarascon Pharmacopoeia mobile app for iPhone, iPad, and Android devices. Enjoy 25% off on Monday, February 29th!

For this year’s Rare Disease Day, we also wanted to highlight a particularly fascinating uncommon condition. Throughout remote towns in Spain and Ecuador, 350 people are diagnosed with Laron’s Disease—a genetic disorder that stops them from growing over four feet tall. Laron’s Syndrome was discovered in 1950 and all 350 people currently diagnosed with Laron’s are descended from a single ancestor with the mutated gene thousands of years ago. Unlike those with dwarfism, people with Laron’s Disease don’t lack a growth hormone, but instead, have mutations in the GHR gene. This gene triggers the growth hormone receptor that binds to the growth hormone. When the receptor binds to the hormone, it triggers the production of the growth-promoting hormone, insulin-like growth factor 1 (IGF-1). So in this case, the cells are unable to trigger the normal growth and function of different tissues.

What makes Laron’s Disease particularly interesting for researchers is that those afflicted with this genetic disorder appear to be resistant to cancer, diabetes, and possibly heart disease and Alzheimer’s. In the future, researchers hope to distill the anti-disease properties into a medicine to fight these illnesses.

Posted in Uncategorized | Comments Off on Leap Year is Also Rare Disease Day!

October 4-10 is Mental Illness Awareness Week! #IAmStigmaFree

The first week of October brings awareness to mental illness and highlights issues, provides support, and works to fight stigma associated with mental health. Did you know, 1 in 17 (14 million) Americans live with a major mental illness like depression, schizophrenia, or bi-polar disorder? According to NAMI (National Awareness on Mental Illness), 1 in 4 (62 million) persons are affected by mental illness, 20% of teens 13-18 have a mental illness, and 18% of adults (42 million) cope with anxiety disorders.

Learn more about mental illnesses with our Question and Answer series including these titles: 100 Questions and Answers About Depression, 100 Questions and Answers About Anxiety, and 100 Questions and Answers About Bipolar Disorder. New edition coming soon: 100 Questions and Answers About Schizophrenia: Painful Minds.

Panic Disorder  Women ADHD  Child OCD  Child Depression  Child ADHD

Posted in Uncategorized | Comments Off on October 4-10 is Mental Illness Awareness Week! #IAmStigmaFree

September is Prostate Cancer Awareness Month!

CaptureProstate cancer is common. In 2012, there were an estimated 2,795, 592 (over 2.5 million) men living with prostate cancer in the United States.  It is estimated that there will be 220,800 new cases of prostate cancer in 2015, accounting for 13.3% of all new cancer cases.  Approximately 27,540 men will die from prostate cancer in 2015. (SEER Stat fact sheets: prostate cancer) It is likely that you know someone, a spouse, significant other, family member or friend with prostate cancer.

The diagnosis is alarming – the choices can be daunting – and feeling overwhelmed is not uncommon.

Trying to navigate one’s way through the evaluation and management of prostate cancer can be akin to walking through a maze and the ongoing advances can add to further confusion.

The evaluation and management of prostate cancer continues to evolve, with a greater understanding of the natural history of prostate cancer, the biology of the cancer cells, refinements in surgical and radiation therapy techniques as well as therapeutic options for recurrent and metastatic prostate cancer.

The adoption of “active surveillance” in select individuals, refinements in surgical procedures, such as robotic assisted laparoscopic radical prostatectomy, and the development of multiple therapies for the management of castrate resistant prostate cancer, prostate cancer cells that continue to grow despite hormone therapy have developed more recently.

Prostate cancer patients, their families, and significant others are faced with difficult treatment choices, often at a time when emotionally they are most impacted.  How do these individuals gather the information they need to make an educated decision or feel “empowered to ask questions”? The internet, although a resource for information, may be difficult to navigate and unfortunately may provide single experiences that don’t reflect the “typical”.  Updating the 100 Questions and Answers: Prostate Cancer attempts to provide current information regarding the diagnosis, evaluation and management of prostate cancer to help prostate cancer patients and their families and significant others feel empowered to ask questions and make treatment decisions.  Knowledge is power – feel empowered to take a more active role in your care or the care of a loved one, spouse or friend.

Post written by Pamela Ellsworth, MD. Pamela Ellsworth is the author of 100 Questions & Answers About Prostate Cancer, 20 Questions & Answers About Metastatic Castration-Resistant Prostate Cancer, 100 Questions & Answers About Men’s Health, among others.

Posted in Uncategorized | Comments Off on September is Prostate Cancer Awareness Month!